Exploring the Mechanism of Aspirin in the Treatment of Kawasaki Disease Based on Molecular Docking and Molecular Dynamics

Figure 5

Molecular docking of active ingredients and hub targets. (a) Aspirin/CTSG, (b) Aspirin/FGF1, (c) Aspirin/ELANE.